Literature DB >> 10789510

Inhibition of HIV-1 infection by an intramolecular antisense peptide to T20 in gp160.

M Imai1, N Okada, H Okada.   

Abstract

Antisense amino acids are amino acids which can be translated from the corresponding anti-codons of a sense amino acid. Antisense peptides encoded by the noncoding DNA strand have a tendency to interact with each other. We have demonstrated that antisense peptide sequences are present intramolecularly, and these may contribute to the folding and maintenance of the tertiary structure of a protein. T20 is a synthetic peptide with an amino acid sequence in the gp41 of HIV-1 and has been demonstrated to be a potent inhibitor of HIV-1 infection. We searched for intramolecular peptide sequences which are antisense to portions of T20. A synthetic peptide (TA-1L) consisting of amino acids 84 to 97 of gp160, which contains an antisense peptide sequence (TA-1) to T20, was shown to inhibit HIV-1(IIIB) infection of MT-4 cells. Interaction of these antisense peptides could be involved in sustaining HIV-1 infectivity. The TA-1L site, which exists in the C1 domain of gp160, is highly homologous among strains of HIV-1, especially at TA-1 and in the amino acids flanking the C terminus. Although the TA-1 sites of 18 out of 30 HIV-1 strains were antisense to the T20 region, those of the remaining 12 strains, including HIV-1(MN), were not. However, TA-1L inhibited infection by HIV-1(MN), which has no antisense peptide in T20 corresponding to TA-1, although the inhibitory effect was weaker. TA-1L may thus also interfere with the gp160 interaction with CD4, which has an antisense sequence to TA-1.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10789510     DOI: 10.1111/j.1348-0421.2000.tb02485.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  10 in total

1.  Small molecules blocking the entry of severe acute respiratory syndrome coronavirus into host cells.

Authors:  Ling Yi; Zhengquan Li; Kehu Yuan; Xiuxia Qu; Jian Chen; Guangwen Wang; Hong Zhang; Hongpeng Luo; Lili Zhu; Pengfei Jiang; Lirong Chen; Yan Shen; Min Luo; Guoying Zuo; Jianhe Hu; Deliang Duan; Yuchun Nie; Xuanling Shi; Wei Wang; Yang Han; Taisheng Li; Yuqing Liu; Mingxiao Ding; Hongkui Deng; Xiaojie Xu
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

2.  Structure of the fusion core and inhibition of fusion by a heptad repeat peptide derived from the S protein of Middle East respiratory syndrome coronavirus.

Authors:  Jing Gao; Guangwen Lu; Jianxun Qi; Yan Li; Ying Wu; Yao Deng; Heyuan Geng; Hongbin Li; Qihui Wang; Haixia Xiao; Wenjie Tan; Jinghua Yan; George F Gao
Journal:  J Virol       Date:  2013-09-25       Impact factor: 5.103

3.  Identification of a peptide derived from the heptad repeat 2 region of the porcine epidemic diarrhea virus (PEDV) spike glycoprotein that is capable of suppressing PEDV entry and inducing neutralizing antibodies.

Authors:  Pengwei Zhao; Bin Wang; Chun-Miao Ji; Xiaoyan Cong; Ming Wang; Yao-Wei Huang
Journal:  Antiviral Res       Date:  2017-12-05       Impact factor: 5.970

4.  Design of histidine-rich peptides with enhanced bioavailability and inhibitory activity against hepatitis C virus.

Authors:  Wei Hong; Runhong Zhang; Zhiyong Di; Yawen He; Zhenhuan Zhao; Jun Hu; Yingliang Wu; Wenxin Li; Zhijian Cao
Journal:  Biomaterials       Date:  2013-02-13       Impact factor: 12.479

5.  Bioengineered in Vitro Tissue Models to Study SARS-CoV-2 Pathogenesis and Therapeutic Validation.

Authors:  Juhi Chakraborty; Indranil Banerjee; Raju Vaishya; Sourabh Ghosh
Journal:  ACS Biomater Sci Eng       Date:  2020-11-16

Review 6.  Potential "biopeptidal" therapeutics for severe respiratory syndrome coronaviruses: a review of antiviral peptides, viral mechanisms, and prospective needs.

Authors:  Tolulope Joshua Ashaolu; Asad Nawaz; Noman Walayat; Ibrahim Khalifa
Journal:  Appl Microbiol Biotechnol       Date:  2021-04-19       Impact factor: 4.813

Review 7.  Can Carbon Quantum Dots (CQDs) or Boron Compounds be an Ultimate Solution for COVID-19 Therapy?

Authors:  Gamze Camlik; Esra Kupeli Akkol; Zelihagul Degim; Ismail Tuncer Degim
Journal:  Iran J Pharm Res       Date:  2021       Impact factor: 1.696

8.  Suppression of SARS-CoV entry by peptides corresponding to heptad regions on spike glycoprotein.

Authors:  Kehu Yuan; Ling Yi; Jian Chen; Xiuxia Qu; Tingting Qing; Xi Rao; Pengfei Jiang; Jianhe Hu; Zikai Xiong; Yuchun Nie; Xuanling Shi; Wei Wang; Chen Ling; Xiaolei Yin; Keqiang Fan; Luhua Lai; Mingxiao Ding; Hongkui Deng
Journal:  Biochem Biophys Res Commun       Date:  2004-07-02       Impact factor: 3.575

Review 9.  Peptides: Prospects for Use in the Treatment of COVID-19.

Authors:  Vladimir Khavinson; Natalia Linkova; Anastasiia Dyatlova; Boris Kuznik; Roman Umnov
Journal:  Molecules       Date:  2020-09-24       Impact factor: 4.411

10.  Crystal structure of severe acute respiratory syndrome coronavirus spike protein fusion core.

Authors:  Yanhui Xu; Zhiyong Lou; Yiwei Liu; Hai Pang; Po Tien; George F Gao; Zihe Rao
Journal:  J Biol Chem       Date:  2004-09-01       Impact factor: 5.157

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.